Market Place
Sourcing Support
Glenmark Pharma launches Empagliflozin and combinations in India
13 Mar 2025 //
INDPHARMAPOST
Glenmark Therapeutics launches Polyethylene Glycol 3350
11 Mar 2025 //
PR NEWSWIRE
Glenmark recalls 1.5M bottles of ADHD drug due to impurities
05 Mar 2025 //
FIERCE PHARMA
Glenmark USA Launches Acetylcysteine Injection 6g/30mL Vial
03 Mar 2025 //
PR NEWSWIRE
FDA Issues Form 483 to Glenmark Pharmaceuticals
03 Mar 2025 //
FDA
Glenmark recalls 1.5 million bottles of ADHD medication in US
02 Mar 2025 //
BUSINESS STD
Glenmark launches Epinephrine injection in US
28 Feb 2025 //
ECONOMICTIMES
Enforcement Report - Week of February 26, 2025
26 Feb 2025 //
FDA
Glenmark Settles U.S. Antitrust Lawsuits for $7M
24 Feb 2025 //
BUSINESS STD
Glenmark, FDC Recall Products From U.S. Over Quality Issues
17 Feb 2025 //
BUSINESS STD
Glenmark Pharma reports Q3 FY25 PAT at Rs. 348 Cr
17 Feb 2025 //
INDPHARMAPOST
India`s Glenmark Pharma Misses Profit Estimates In Q3
14 Feb 2025 //
REUTERS
Glenmark Pharmaceuticals launches Latanoprost Ophthalmic Solution
14 Feb 2025 //
PR NEWSWIRE
Glenmark launches generic ophthalmic solution in US market
13 Feb 2025 //
ECONOMICTIMES
Glenmark launches Clindamycin Phosphate Foam
13 Feb 2025 //
BUSINESS STD
Enforcement Report - Week of February 12, 2025
12 Feb 2025 //
FDA
Glenmark, Cosmo get MHRA nod to acne treatment in UK
10 Feb 2025 //
BUSSINESS STD
Glenmark share rises 2% as unit launches blood clotting drug
21 Jan 2025 //
BUSINESS STD
Glenmark Pharm launch of coagulation disorder drug Phytonadione
21 Jan 2025 //
BUSINESS STD
Enforcement Report - Week of January 1, 2025
01 Jan 2025 //
FDA
Glenmark USA launches Lacosamide Oral Solution, 10 mg/mL
18 Dec 2024 //
INDPHARMAPOST
Glenmark Pharma Shares Up 2% on Rolling Out Lacosamide Solution
16 Dec 2024 //
BUSINESS STD
Glenmark Pharma arm launches seizure drug in US
16 Dec 2024 //
BUSSINESS STD
Aurobindo, Glenmark, Zydus Recall Products in US Over Manufacturing
15 Dec 2024 //
BUSINESS STD
Enforcement Report - Week of December 11, 2024
11 Dec 2024 //
FDA
Glenmark Pharma Gains 4% On Positive Antibody Drug Trials
10 Dec 2024 //
BUSINESS STD
Ichnos Glenmark Presents Data on ISB 2001 in Multiple Myeloma
09 Dec 2024 //
GLOBENEWSWIRE
Glenmark Pharma arm launches Travoprost Ophthalmic Solution in US
27 Nov 2024 //
BUSINESS STD
Glenmark to focus on becoming branded company
19 Nov 2024 //
ECONOMICTIMES
Glenmark arm recalls products in US for manufacturing issues
13 Oct 2024 //
ECONOMICTIMES
Enforcement Report - Week of October 9, 2024
09 Oct 2024 //
FDA
Enforcement Report - Week of October 2, 2024
02 Oct 2024 //
FDA
Ichnos-Glenmark Antibody Outperforms J&J`s Tecvayli In Mice Study
17 Sep 2024 //
FIERCE BIOTECH
Glenmark to pay USD 25 mn as part of settlement with US authorities
05 Sep 2024 //
ECONOMICTIMES
Glenmark Launches OTC Olopatadine Hydrochloride Ophthalmic Solution
19 Aug 2024 //
PR NEWSWIRE
Glenmark Therapeutics launches Olopatadine Hydrochloride Ophthalmic Solution USP
19 Aug 2024 //
INDIANPHARMAPOST
Glenmark Pharma reports Q1 FY25 consolidated PAT at Rs. 340.2 Cr
15 Aug 2024 //
INDIANPHARMAPOST
Enforcement Report for Week of August 7, 2024
07 Aug 2024 //
FDA
Enforcement Report - Week of July 24, 2024
24 Jul 2024 //
FDA
Glenmark Pharma gets USFDA nod for seizure treatment drug
17 Jul 2024 //
MONEYCONTROL
Glenmark and IADVL undertake awareness campaign to support Vitiligo in India
26 Jun 2024 //
PHARMABIZ
Glenmark recalls 114 batches of low potassium drug in the US
26 Jun 2024 //
FIERCE PHARMA
Glenmark USA Issues Voluntary Nationwide Recall for KCL ER Capsule
26 Jun 2024 //
FDA
Glenmark gets USFDA nod to market generic drug
12 Jun 2024 //
ECONOMICTIMES
Glenmark`s Generic Esomeprazole Magnesium Receives Approval in US
11 Jun 2024 //
FDA
Glenmark Pharma concludes Hypertension Awareness Month in India
29 May 2024 //
PHARMABIZ
Glenmark unit ties up with BeiGene to market cancer drugs in India
21 May 2024 //
MONEYCONTROL
Glenmark amplifies Nationwide Heart Health ‘India First Heart First’ campaign
18 May 2024 //
PHARMABIZ
Glenmark receives ANDA approval for Brimonidine Tartrate & Timolol Maleate
18 May 2024 //
INDINPHARMAPOST
Glenmark receives US FDA approval for brimonidine tartrate and timolol maleate
17 May 2024 //
PHARMABIZ
Glenmark launches next phase of ‘India First Heart First’ campaign
17 May 2024 //
INDINPHARMAPOST
Cipla and Glenmark initiate recall of certain products in the US
06 May 2024 //
PHARMACEUTICAL TECHNOLOGY
Enforcement Report - Week of May 1, 2024
01 May 2024 //
FDA
Glenmark Pharma gets USFDA nod for generic anti-inflammatory drug
29 Apr 2024 //
ECONOMICTIMES
Glenmark recalls 6,528 bottles of blood pressure drug in US
15 Apr 2024 //
ECONOMICTIMES
Lupin, Glenmark recall drugs in US market: USFDA
10 Apr 2024 //
MONEYCONTROL
Enforcement Report - Week of April 10, 2024
10 Apr 2024 //
FDA
Delhi High Court seeks response from govt, NPPA on Glenmark`s plea
09 Apr 2024 //
ECONOMIC TIMES
Maharashtra FDA begins probe stickering & mislabelling on Glenmark`s drug Telma
05 Apr 2024 //
DERUG CONTROL
